A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease
Chemical Biology and Drug Design
NOVEMBER 4, 2024
Alzheimer's disease (AD) is a progressive age-related neurodegenerative brain disorder that destroys memory and other important mental functions. This review article comprehensively summarized the recent advancements in galantamine and its hybrid analogs as potential therapeutic agents for the management of AD. Furthermore, we also provided the design, synthesis, and SAR analysis of the galantamine-based compounds used in the last decades for the management of AD.
Let's personalize your content